These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11889350)

  • 1. Fatigue, decreased interest in play, motor delay, and elevated liver function tests in a 4-year-old boy.
    Stein MT; Tipnis NA; Schultz P
    J Dev Behav Pediatr; 2002 Feb; 23(1):37-41. PubMed ID: 11889350
    [No Abstract]   [Full Text] [Related]  

  • 2. Early diagnosis of Duchenne muscular dystrophy with high level of transaminases.
    Kurul S; Ulgenalp A; Dirik E; Ercal D
    Indian Pediatr; 2002 Feb; 39(2):210-1. PubMed ID: 11867860
    [No Abstract]   [Full Text] [Related]  

  • 3. Early symptoms of Duchenne muscular dystrophy--description of cases of an 18-month-old and an 8-year-old patient.
    Iwańczak F; Stawarski A; Potyrała M; Siedlecka-Dawidko J; Agrawal GS
    Med Sci Monit; 2000; 6(3):592-5. PubMed ID: 11208376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short stature and high serum transaminase levels: growth hormone deficiency in a child with Becker muscular dystrophy.
    Gaudino R; Piona C; Morandi G; Maines E; Banzato C; Tonin P; Scarpelli M; Cavarzere P; Antoniazzi F
    Minerva Pediatr; 2017 Oct; 69(5):460-462. PubMed ID: 28745468
    [No Abstract]   [Full Text] [Related]  

  • 5. Aminotransferases and muscular diseases: a disregarded lesson. Case reports and review of the literature.
    Veropalumbo C; Del Giudice E; Esposito G; Maddaluno S; Ruggiero L; Vajro P
    J Paediatr Child Health; 2012 Oct; 48(10):886-90. PubMed ID: 20500440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty liver disease and hypertransaminasemia hiding the association of clinically silent Duchenne muscular dystrophy and hereditary fructose intolerance.
    Paolella G; Pisano P; Albano R; Cannaviello L; Mauro C; Esposito G; Vajro P
    Ital J Pediatr; 2012 Oct; 38():64. PubMed ID: 23114028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue, decreased interest in play, motor delay, and elevated liver function tests in a 4-year-old boy.
    Stein MT; Tipnis NA; Schultz P
    J Dev Behav Pediatr; 2004 Oct; 25(5 Suppl):S38-42. PubMed ID: 15502531
    [No Abstract]   [Full Text] [Related]  

  • 8. Disabilities in children with Duchenne muscular dystrophy: a profile.
    Nair KP; Vasanth A; Gourie-Devi M; Taly AB; Rao S; Gayathri N; Murali T
    J Rehabil Med; 2001 Jul; 33(4):147-9. PubMed ID: 11506211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum transaminase levels in boys with Duchenne and Becker muscular dystrophy.
    McMillan HJ; Gregas M; Darras BT; Kang PB
    Pediatrics; 2011 Jan; 127(1):e132-6. PubMed ID: 21149430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: A cross-sectional analysis.
    Schmidt S; Hafner P; Klein A; Rubino-Nacht D; Gocheva V; Schroeder J; Naduvilekoot Devasia A; Zuesli S; Bernert G; Laugel V; Bloetzer C; Steinlin M; Capone A; Gloor M; Tobler P; Haas T; Bieri O; Zumbrunn T; Fischer D; Bonati U
    Neuromuscul Disord; 2018 Jan; 28(1):16-23. PubMed ID: 29174526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.
    Hafner P; Bonati U; Rubino D; Gocheva V; Zumbrunn T; Gueven N; Fischer D
    Trials; 2016 Aug; 17(1):389. PubMed ID: 27488051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CUGC for Duchenne muscular dystrophy (DMD).
    Coote DJ; Davis MR; Cabrera M; Needham M; Laing NG; Nowak KJ
    Eur J Hum Genet; 2018 May; 26(5):749-757. PubMed ID: 29330543
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetics and emerging treatments for Duchenne and Becker muscular dystrophy.
    Wein N; Alfano L; Flanigan KM
    Pediatr Clin North Am; 2015 Jun; 62(3):723-42. PubMed ID: 26022172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serum nitric oxide levels in patients with Duchenne muscular dystrophy.
    Gücüyener K; Ergenekon E; Erbas D; Pinarli G; Serdaroğlu A
    Brain Dev; 2000 May; 22(3):181-3. PubMed ID: 10814901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevations of serum glutamic-oxalacetic transaminase and urinary coproporphyrins in pseudohypertrophic muscular dystrophy.
    RITTER JA; SELIGSON D
    Am J Med Sci; 1957 May; 233(5):559-62. PubMed ID: 13410932
    [No Abstract]   [Full Text] [Related]  

  • 16. Strong correlation between the 6-minute walk test and accelerometry functional outcomes in boys with Duchenne muscular dystrophy.
    Davidson ZE; Ryan MM; Kornberg AJ; Walker KZ; Truby H
    J Child Neurol; 2015 Mar; 30(3):357-63. PubMed ID: 24762862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of 18 cases of Becker muscular dystrophy].
    Bernal Sánchez-Arjona M; Sanz-Fernández G; Travado-Soria P; Fernández-García R; Chinchón-Lara I; Antiñolo G; Bautista-Lorite J
    Rev Neurol; 2004 Jun 1-15; 38(11):1090-2. PubMed ID: 15202090
    [No Abstract]   [Full Text] [Related]  

  • 18. The dystrophy of Duchenne.
    Jay V; Vajsar J
    Lancet; 2001 Feb; 357(9255):550-2. PubMed ID: 11229686
    [No Abstract]   [Full Text] [Related]  

  • 19. Duchenne muscular dystrophy: issues in expanding newborn screening.
    Kemper AR; Wake MA
    Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation.
    Desguerre I; Mayer M; Leturcq F; Barbet JP; Gherardi RK; Christov C
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):762-73. PubMed ID: 19535995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.